Panagora Asset Management Inc Immuno Gen, Inc. Transaction History

Panagora Asset Management Inc

$20.5 Billion
Q3 2024

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 08, 2024	SELL	$12.46 - $29.95 $8.58 Million - $20.6 Million	-688,759 Reduced 62.7%	409,658 $12.1 Million
Q3 2023 Oct 31, 2023	SELL	$14.09 - $19.87 $275,487 - $388,498	-19,552 Reduced 1.75%	1,098,417 $17.4 Million
Q2 2023 Aug 11, 2023	SELL	$3.75 - $20.05 $371,898 - $1.99 Million	-99,173 Reduced 8.15%	1,117,969 $21.1 Million
Q1 2023 May 11, 2023	BUY	$3.67 - $4.92 $535,052 - $717,291	145,791 Added 13.61%	1,217,142 $4.67 Million
Q4 2022 Feb 13, 2023	SELL	$4.55 - $6.31 $43,939 - $60,935	-9,657 Reduced 0.89%	1,071,351 $5.31 Million
Q3 2022 Nov 14, 2022	SELL	$4.48 - $6.47 $359,318 - $518,926	-80,205 Reduced 6.91%	1,081,008 $5.17 Million
Q2 2022 Aug 15, 2022	SELL	$3.15 - $5.76 $39,822 - $72,817	-12,642 Reduced 1.08%	1,161,213 $5.23 Million
Q1 2022 May 12, 2022	BUY	$4.26 - $7.48 $167,780 - $294,599	39,385 Added 3.47%	1,173,855 $5.59 Million
Q4 2021 Feb 10, 2022	SELL	$4.75 - $7.5 $60,439 - $95,430	-12,724 Reduced 1.11%	1,134,470 $8.42 Million
Q3 2021 Nov 10, 2021	BUY	$5.02 - $6.59 $105,967 - $139,108	21,109 Added 1.87%	1,147,194 $6.51 Million
Q2 2021 Aug 11, 2021	SELL	$5.79 - $8.6 $502,710 - $746,686	-86,824 Reduced 7.16%	1,126,085 $7.42 Million
Q1 2021 May 12, 2021	SELL	$6.5 - $10.53 $651,092 - $1.05 Million	-100,168 Reduced 7.63%	1,212,909 $9.83 Million
Q4 2020 Feb 10, 2021	BUY	$3.7 - $7.66 $564,490 - $1.17 Million	152,565 Added 13.15%	1,313,077 $8.47 Million
Q3 2020 Nov 13, 2020	SELL	$3.45 - $4.89 $2.31 Million - $3.27 Million	-668,248 Reduced 36.54%	1,160,512 $4.18 Million
Q2 2020 Aug 12, 2020	BUY	$3.32 - $5.34 $759,224 - $1.22 Million	228,682 Added 14.29%	1,828,760 $8.41 Million
Q1 2020 May 14, 2020	SELL	$2.12 - $6.8 $1.07 Million - $3.43 Million	-504,139 Reduced 23.96%	1,600,078 $5.46 Million
Q4 2019 Feb 12, 2020	BUY	$2.25 - $5.8 $612,297 - $1.58 Million	272,132 Added 14.85%	2,104,217 $10.7 Million
Q3 2019 Nov 12, 2019	BUY	$2.22 - $3.39 $827,966 - $1.26 Million	372,958 Added 25.56%	1,832,085 $4.43 Million
Q2 2019 Aug 09, 2019	BUY	$1.8 - $3.3 $147,085 - $269,656	81,714 Added 5.93%	1,459,127 $3.17 Million
Q1 2019 May 15, 2019	BUY	$2.41 - $5.91 $666,066 - $1.63 Million	276,376 Added 25.1%	1,377,413 $3.73 Million
Q4 2018 Feb 14, 2019	BUY	$3.94 - $9.7 $647,141 - $1.59 Million	164,249 Added 17.53%	1,101,037 $5.29 Million
Q3 2018 Nov 13, 2018	BUY	$8.6 - $11.26 $287,936 - $376,996	33,481 Added 3.71%	936,788 $8.87 Million
Q2 2018 Aug 14, 2018	BUY	$9.52 - $12.15 $472,258 - $602,725	49,607 Added 5.81%	903,307 $8.79 Million
Q1 2018 May 15, 2018	BUY	$6.7 - $12.95 $935,541 - $1.81 Million	139,633 Added 19.55%	853,700 $8.98 Million
Q4 2017 Feb 14, 2018	SELL	$5.07 - $7.92 $1.04 Million - $1.63 Million	-205,442 Reduced 22.34%	714,067 $4.58 Million
Q3 2017 Nov 14, 2017	BUY	$5.4 - $8.47 $4.97 Million - $7.79 Million	919,509	919,509 $7.03 Million

Others Institutions Holding IMGN

# of Institutions

Shares Held

1.41M

Call Options Held

Put Options Held

View Full List

About ImmunoGen, Inc.

Ticker IMGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 220,712,992
Description
ImmunoGen, Inc., a clinical-stage biotechnology company, develops antibody-drug conjugate (ADC) therapies to treat cancer. The company's product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha (FRa), which is in Phase III clinical trial for the treatment of platinum-resistant ovarian cancer; and Pivekimab sun...

More about IMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Panagora Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Panagora Asset Management Inc with notifications on news.

Account